The acquisition of methamphetamine for authorized research or therapeutic purposes presents specific difficulties for institutions. Ensuring compliance with federal regulations and strict reporting requirements is absolutely vital. This procedure often involves thorough record documentation, careful inventory controls, and periodic reviews. Further